Dr. Daniel Geschwind has been appointed senior associate dean and associate vice chancellor of precision medicine in the UCLA Health System and David Geffen School of Medicine. His appointment takes effect March 1.
In this newly created position, he will be responsible for coordinating all precision medicine efforts in the health system and school, leading a unit that has responsibility for creating and running an integrated precision medicine diagnostic service, including genomics and other specialized testing services, associated bioinformatics and biobanking. He will be the principal UCLA representative in intercampus precision medicine efforts and in regional genomics initiatives that may be undertaken with non-UC institutions in Southern California.
He will direct a new Institute for precision medicine, which will be developed and serve as the home for precision and genomic medicine activities on campus.
Geschwind is Gordon and Virginia MacDonald Distinguished Chair in Human Genetics, professor of neurology and psychiatry and biobehavioral sciences, director of the Center for Autism Research and Treatment, and co-director of the Center for Neurobehavioral Genetics.
A highly accomplished neuroscientist, Geschwind and his team are working on integrating basic neurobiology, genetics and genomics with translational studies of neurodevelopmental and neurodegenerative conditions, focusing on autism spectrum disorders, dementia, neural repair and inherited ataxia.
His lab has pioneered the application of gene expression and network methods in neurologic and psychiatric disease, working in collaboration with dozens of other laboratories to connect molecular pathways to nervous system function. Their goal is to develop new therapeutics for nervous system disorders for which therapies are not currently available.
Geschwind has also helped foster large-scale, collaborative patient resources for genetic research and data sharing. He played a major role in the establishing the Autism Genetic Resource Exchange, the largest collection of multiplex autism families in the world, and continues to provide scientific oversight.
Dr. Geschwind received an A.B. degree in psychology and chemistry at Dartmouth College, and his M.D. and Ph.D. degrees at Yale University School of Medicine. He completed a neurology residency at UCLA and joined the faculty in 1997. He is an elected member of the National Academy of Medicine.